These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37641532)

  • 21. Combining biomarkers for classification with covariate adjustment.
    Kim S; Huang Y
    Stat Med; 2017 Jul; 36(15):2347-2362. PubMed ID: 28276080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical likelihood inference in randomized clinical trials.
    Zhang B
    Stat Methods Med Res; 2018 Dec; 27(12):3770-3784. PubMed ID: 28679341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAPTIVE MATCHING IN RANDOMIZED TRIALS AND OBSERVATIONAL STUDIES.
    van der Laan MJ; Balzer LB; Petersen ML
    J Stat Res; 2012 Dec; 46(2):113-156. PubMed ID: 25097298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Balance Super Learner: A robust adaptation of the Super Learner to improve estimation of the average treatment effect in the treated based on propensity score matching.
    Pirracchio R; Carone M
    Stat Methods Med Res; 2018 Aug; 27(8):2504-2518. PubMed ID: 28339317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covariate adjustment and estimation of mean response in randomised trials.
    Bartlett JW
    Pharm Stat; 2018 Sep; 17(5):648-666. PubMed ID: 29998483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.
    Yuan S; Zhang HH; Davidian M
    Stat Med; 2012 Dec; 31(29):3789-804. PubMed ID: 22733628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced precision in the analysis of randomized trials with ordinal outcomes.
    Díaz I; Colantuoni E; Rosenblum M
    Biometrics; 2016 Jun; 72(2):422-31. PubMed ID: 26576013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of average treatment effect based on a multi-index propensity score.
    Xu J; Wei K; Wang C; Huang C; Xue Y; Zhang R; Qin G; Yu Y
    BMC Med Res Methodol; 2022 Dec; 22(1):337. PubMed ID: 36577950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of propensity scores and observational data to estimate randomized controlled trial generalizability bias.
    Pressler TR; Kaizar EE
    Stat Med; 2013 Sep; 32(20):3552-68. PubMed ID: 23553373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying surrogate markers in real-world comparative effectiveness research.
    Han L; Wang X; Cai T
    Stat Med; 2022 Nov; 41(26):5290-5304. PubMed ID: 36062392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal auxiliary-covariate-based two-phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials.
    Gilbert PB; Yu X; Rotnitzky A
    Stat Med; 2014 Mar; 33(6):901-17. PubMed ID: 24123289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of dynamic block randomization and minimization in randomized trials: a simulation study.
    Xiao L; Lavori PW; Wilson SR; Ma J
    Clin Trials; 2011 Feb; 8(1):59-69. PubMed ID: 21335590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A semiparametric method for evaluating causal effects in the presence of error-prone covariates.
    Liu J; Li W
    Biom J; 2021 Aug; 63(6):1202-1222. PubMed ID: 34357652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variance reduction in the inverse probability weighted estimators for the average treatment effect using the propensity score.
    Liao J; Rohde C
    Biometrics; 2022 Jun; 78(2):660-667. PubMed ID: 33715153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient and robust methods for causally interpretable meta-analysis: Transporting inferences from multiple randomized trials to a target population.
    Dahabreh IJ; Robertson SE; Petito LC; Hernán MA; Steingrimsson JA
    Biometrics; 2023 Jun; 79(2):1057-1072. PubMed ID: 35789478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.